Up a level |
Number of items: 1.
Wiviott, Stephen D, Raz, Itamar, Bonaca, Marc P, Mosenzon, Ofri, Kato, Eri T, Cahn, Avivit, Silverman, Michael G, Zelniker, Thomas A, Kuder, Julia F, Murphy, Sabina A et al (show 11 more authors)
(2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
The New England journal of medicine, 380 (4).
347 - 357.